Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF | DNDEF | T.DC.PR.B | T.DC.PR.D | DNDPF

Healthcare Metals & Mining Technology Gold Silver
Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate... see more

TSX:DC.A - Post Discussion

Dundee Corp > Second Alzheimers drug approved
View:
Post by jrj90620 on Jun 13, 2024 5:42pm

Second Alzheimers drug approved

Hope Tau gets theirs approved soon.
https://www.newsmax.com/health/health-news/alzheimers-drug-fda-lilly-brain-donanemab-leqembi/2024/06/10/id/1168194/?ns_mail_uid=7b79ab85-7620-49dc-b882-2968834d7534&ns_mail_job=DM636847_06132024&s=acs&dkt_nbr=010102htmrc9
Comment by TheCount11 on Jun 17, 2024 10:03am
The sooner TauRx is available for AD patients that can benefit the better! Unfortunately the placebo complication means it will take more time.  Cheers
Dundee Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities